Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-087891
Filing Date
2025-06-18
Accepted
2025-06-18 16:10:48
Documents
2
Period of Report
2025-06-17

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 5813
2 EX-24.1 aura-ex24_1.htm EX-24.1 12968
  Complete submission text file 0000950170-25-087891.txt   20201
Mailing Address 80 GUEST STREET BOSTON MA 02135
Business Address 80 GUEST STREET BOSTON MA 02135 (617)500-8864
Aura Biosciences, Inc. (Issuer) CIK: 0001501796 (see all company filings)

EIN.: 320271970 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O MYOS CORPORATION 45 HORSEHILL ROAD, SUITE 106 CEDAR KNOLLS NJ 07927
Business Address
Srivastava Sapna (Reporting) CIK: 0001569226 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40971 | Film No.: 251057018